EMPIRICAL STUDY PROVES TIGHTER IP PROTECTION HAS CUT INDIAN GENERICS PRODUCTION
May 1st, 2012
BY KEITH NUTHALL
A WORLD Bank study has proved the tightening of intellectual property rights in India has depressed the manufacture of generic drugs and increased market shares for developers of particular active ingredients within patent protected medicines. The study 'Pharmaceutical Patents and Prices: A Preliminary Empirical Assessment Using Data from India' focused on central nervous system drugs (CNS). It conclude that there had been a significant change in the Indian market for these drugs since patent protection increased for medicines under the World ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.